Small- and mid-cap stocks have been on a sharp upswing, but as covid-19 infections soar and as the economic slowdown continues, this run-up may be nearing its limits. Mid-cap stocks have seen their valuations edge past the frontline index. In the past month, the Nifty 50’s increase of 2.9% pales in comparison to the rise of 11% and 16% in the Nifty Midcap 100 and Small-cap 100 indices. After undershooting the broader markets since January 2018, the rise is being seen as an attempt to catch up on valuations.
Nine big financial changes that you must watch out for in October
Read More